About MiMedx Group, Inc. 
MiMedx Group, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 53 Schemes (18.25%)
Foreign Institutions
Held by 89 Foreign Institutions (6.01%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
118 Million
(Quarterly Results - Dec 2025)
Net Profit:
15 Million
Pharmaceuticals & Biotechnology
USD 659 Million (Micro Cap)
16.00
NA
0.00%
-0.52
17.11%
2.76






